Authors

• C D Xia (ORCID: https://orcid.org/0000-0003-0418-0371)
• Maureen R. Hewitt
• Ninian N. Lang (ORCID: https://orcid.org/0000-0001-8441-6887)
• Rebecca A. Hubbard (ORCID: https://orcid.org/0000-0003-0879-0994)
• Yehoda M. Martei (ORCID: https://orcid.org/0000-0002-5631-1567)
• Leah Rethy (ORCID: https://orcid.org/0000-0001-8046-6895)
• G. Michael Felker (ORCID: https://orcid.org/0000-0002-5931-1239)
• Nicholas S. Wilcox (ORCID: https://orcid.org/0000-0002-3693-7650)
• Saro H. Armenian (ORCID: https://orcid.org/0000-0003-2604-8603)
• Daniel J. Landsburg (ORCID: https://orcid.org/0000-0002-5077-4181)
• James Louis Januzzi (ORCID: https://orcid.org/0000-0002-8338-1798)
• Amanda M. Smith (ORCID: https://orcid.org/0000-0002-9881-236X)
• Amy S. Clark (ORCID: https://orcid.org/0000-0002-3685-6535)
• Bénédicte Lefebvre (ORCID: https://orcid.org/0000-0002-8587-7279)
• Vivek Narayan (ORCID: https://orcid.org/0000-0002-8205-738X)
• Anran Huang (ORCID: https://orcid.org/0000-0003-1435-1576)
• Payal D. Shah (ORCID: https://orcid.org/0000-0001-5874-3390)
• Bonnie Ky (ORCID: https://orcid.org/0000-0002-6628-9981)
• Wonyoung Jung (ORCID: https://orcid.org/0000-0003-4749-4637)
• Sophia Golec
• Peter P. Liu (ORCID: https://orcid.org/0000-0002-3017-1199)
• Daniel Koropeckyj-Cox (ORCID: https://orcid.org/0009-0009-6446-3868)
• Zhen Chen
• Liyong Zhang
• Kyunga Ko (ORCID: https://orcid.org/0000-0001-8582-2633)
• Faizi Jamal (ORCID: https://orcid.org/0009-0009-5459-3431)

Institutions

• Tufts Medical Center (US)
• University of Ottawa (CA)
• Duke University (US)
• Brown University (US)
• Hospital of the University of Pennsylvania (US)
• Clinical Research Institute (US)
• City of Hope (US)
• Baim Institute for Clinical Research (US)
• University of Glasgow (GB)
• University of Pennsylvania (US)

Publication Details

Journal

JAMA Network Open

Published

2025-12-03

DOI

https://doi.org/10.1001/jamanetworkopen.2025.46201

Citations

1

Primary Topic

Chemotherapy-induced cardiotoxicity and mitigation

Type

article

Field-Weighted Citation Impact

1.39

Funders

• Eli Lilly and Company
• AstraZeneca
• Genome Canada
• MyoKardia
• National Institutes of Health